Evidence map›Paper›PMID 34960637›Full record

ArticleViruses2021

Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Contaminated Hospital Environments.

Wen-Lin Su, Chih-Pei Lin, Hui-Ching Huang, Yao-Kuang Wu, Mei-Chen Yang, Sheg-Kang Chiu, Ming-Yieh Peng, Ming-Chin Chan, You-Chen Chao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wen-Lin SuDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan.ORCID 0000-0002-9065-2058
Chih-Pei LinSchool of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Hui-Ching HuangDepartment of Pathology and Laboratory Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan.
Yao-Kuang WuDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan.
Mei-Chen YangDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan.ORCID 0000-0002-6503-5189
Sheg-Kang ChiuSchool of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Ming-Yieh PengDivision of Infectious Disease, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan.ORCID 0000-0001-6194-4556
Ming-Chin ChanInfection Control Center, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan.
You-Chen ChaoSchool of Medicine, Tzu Chi University, Hualien 970, Taiwan.

Funding

Taipei Tzu Chi Hospital TCRD-TPE-109-16-2/2
6 · The paper itself

Abstract

To overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, transmission routes, such as healthcare worker infection, must be effectively prevented. Ultraviolet C (UVC) (254 nm) has recently been demonstrated to prevent environmental contamination by infected patients; however, studies on its application in contaminated hospital settings are limited. Herein, we explored the clinical application of UVC and determined its optimal dose. Environmental samples (

Indexed as

Ultraviolet RaysCOVID-19Dose-Response Relationship, RadiationHospitalsHumansInfection ControlSARS-CoV-2Time Factors254 nm Ultraviolet CCOVID-19environmental samplingRT-PCRSARS-CoV-2

Identifiers

PMID34960637
PMCPMC8706350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.